Jump to main content

博士論文

Nafamostat and sepimostat identified as novel neuroprotective agents via NR2B N-methyl-D-aspartate receptor antagonism using a rat retinal excitotoxicity model

Icons representing 博士論文
The cover of this title could differ from library to library.

Available in National Diet Library

Find on the publisher's website

NDL Digital Collections

Digital data available

Check on the publisher's website

DOI[10.1038/s41598-019-56905-x]to the data of the same series

Nafamostat and sepimostat identified as novel neuroprotective agents via NR2B N-methyl-D-aspartate receptor antagonism using a rat retinal excitotoxicity model

Persistent ID (NDL)
info:ndljp/pid/11702453
Material type
博士論文
Author
不破, 正博
Publisher
不破, 正博
Date granted
2020-03-06
Material Format
Digital
Capacity, size, etc.
-
Degree grantor and degree
京都府立医科大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
Nafamostat and sepimostat identified as novel neuroprotective agents via NR2B N-methyl-D-aspartate receptor antagonism using a rat retinal excitotoxicity model
Author/Editor
不破, 正博
Publication, Distribution, etc.
不破, 正博
Publication Date
2020
Publication Date (W3CDTF)
2020
Alternative Title
ラット興奮性網膜障害モデルにおいて同定された神経保護薬ナファモスタットおよびセピモスタットは新規NR2B NMDA受容体拮抗薬である
Degree Grantor
京都府立医科大学
Date Granted
2020-03-06
Date Granted (W3CDTF)
2020-03-06